were the first to identify that exosomes derived from hypoxic brain cancer exhibited notably elevated levels of monocarboxylate transporter 1 (MCT1) and CD147 (a transmembrane glycoprotein associated with tumors). This evidence concerns the gene BSG and brain cancer.